Nanomedicines for Tumor-Associated Macrophages

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Handbook of Oxidative Stress in Cancer: Therapeutic Aspects

• Publication date

  2021-12-14

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/978-981-16-1247-3_265-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes

  2021cited by this paper
• Targeting tumor-associated macrophages to synergize tumor immunotherapy

  2021cited by this paper
• Targeting macrophages: a novel avenue for cancer drug discovery

  2020cited by this paper
• Targeting Tumor-Associated Macrophages by MMP2-Sensitive Apoptotic Body-Mimicking Nanoparticles.

  2020cited by this paper
• Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles

  2020cited by this paper
• Targeted delivery of zoledronic acid through the sialic acid siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - A promising cancer immunotherapy.

  2020cited by this paper
• Role of Nanobiotechnology in Drug Discovery, Development and Molecular Diagnostic

  2020cited by this paper
• Engineering precision nanoparticles for drug delivery

  2020cited by this paper
• Manipulating the function of tumor-associated macrophages by siRNA-loaded lipid nanoparticles for cancer immunotherapy.

  2020cited by this paper
• Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer

  2020cited by this paper
• Folate receptor-targeted RNAi nanoparticles for silencing STAT3 in tumor-associated macrophages and tumor cells.

  2020cited by this paper
• Biology and therapeutic targeting of tumour‐associated macrophages

  2020cited by this paper
• Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.

  2020cited by this paper
• Tumor-macrophage crosstalk: how to listen.

  2020cited by this paper
• The controlled synthesis of complex hollow nanostructures and prospective applications†

  2019cited by this paper
• Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy.

  2019cited by this paper
• Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy.

  2019cited by this paper
• Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?

  2019cited by this paper
• Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer

  2019cited by this paper
• Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages

  2019cited by this paper
• Targeted Delivery of miRNA 155 to Tumor Associated Macrophages for Tumor Immunotherapy.

  2019cited by this paper
• Tailoring Nanomaterials for Targeting Tumor‐Associated Macrophages

  2019cited by this paper
• Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth

  2019cited by this paper
• Biological Effects of Nanoparticles on Macrophage Polarization in the Tumor Microenvironment

  2019cited by this paper
• CSF1R‐ and SHP2‐Inhibitor‐Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor‐Associated Macrophages

  2019cited by this paper
• Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy.

  2019cited by this paper
• Multifunctional biomimetic nanoparticles loading baicalin for polarizing tumor-associated macrophages.

  2019cited by this paper
• Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers

  2019cited by this paper
• Utilizing glutathione‐triggered nanoparticles to enhance chemotherapy of lung cancer by reprograming the tumor microenvironment

  2018cited by this paper
• Gold‐manganese oxide nanocomposite suppresses hypoxia and augments pro‐inflammatory cytokines in tumor associated macrophages

  2018cited by this paper
• Glycocalyx-Mimicking Nanoparticles Improve Anti-PD-L1 Cancer Immunotherapy through Reversion of Tumor-Associated Macrophages.

  2018cited by this paper
• Cationic Polymeric Nanoparticle Delivering CCR2 siRNA to Inflammatory Monocytes for Tumor Microenvironment Modification and Cancer Therapy.

  2018cited by this paper
• Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.

  2018cited by this paper
• Targeting Macrophages in Cancer: From Bench to Bedside

  2018cited by this paper
• Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions

  2018cited by this paper
• Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression

  2018cited by this paper
• TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy

  2018cited by this paper
• Calcium Bisphosphonate Nanoparticles with Chelator-Free Radiolabeling to Deplete Tumor-Associated Macrophages for Enhanced Cancer Radioisotope Therapy.

  2018cited by this paper
• Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment.

  2017cited by this paper
• Tissue‐Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression

  2017cited by this paper
• Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity.

  2017cited by this paper
• Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.

  2017cited by this paper
• Diverse Applications of Nanomedicine

  2017cited by this paper
• Polyhydroxylated fullerenols regulate macrophage for cancer adoptive immunotherapy and greatly inhibit the tumor metastasis.

  2016cited by this paper
• Nanoparticles in the clinic

  2016cited by this paper
• Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.

  2016cited by this paper
• Targeted delivery of nano-PTX to the brain tumor-associated macrophages

  2016cited by this paper
• Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia.

  2016cited by this paper
• A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects.

  2016cited by this paper
• Smart Superstructures with Ultrahigh pH-Sensitivity for Targeting Acidic Tumor Microenvironment: Instantaneous Size Switching and Improved Tumor Penetration.

  2016cited by this paper
• Biocompatible mannosylated endosomal-escape nanoparticles enhance selective delivery of short nucleotide sequences to tumor associated macrophages.

  2015cited by this paper
• Pro-inflammatory responses of RAW264.7 macrophages when treated with ultralow concentrations of silver, titanium dioxide, and zinc oxide nanoparticles.

  2015cited by this paper
• Size Effects of Nanocomplex on Tumor Associated Macrophages Targeted Delivery for Glioma

  2015cited by this paper
• Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

  2015cited by this paper
• A novel nitric oxide-based anticancer therapeutics by macrophage-targeted poly(l-arginine)-based nanoparticles.

  2015cited by this paper
• Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi‐Peptide Nanoparticles to Tumor‐Associated Macrophages and Cancer Cells

  2015cited by this paper
• Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy.

  2014cited by this paper
• Tumor-associated macrophages: from mechanisms to therapy.

  2014cited by this paper
• Biodistribution and in Vivo Activities of Tumor-Associated Macrophage-Targeting Nanoparticles Incorporated with Doxorubicin

  2014cited by this paper
• Development of Y-shaped peptide for constructing nanoparticle systems targeting tumor-associated macrophages in vitro and in vivo

  2014cited by this paper
• Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles.

  2013cited by this paper
• Macrophage-specific RNA interference targeting via "click", mannosylated polymeric micelles.

  2013cited by this paper
• Anti‐tumour strategies aiming to target tumour‐associated macrophages

  2013cited by this paper
• Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages.

  2013cited by this paper
• Dysregulation of macrophage activation profiles by engineered nanoparticles.

  2013cited by this paper
• The interactions between pristine graphene and macrophages and the production of cytokines/chemokines via TLR- and NF-κB-related signaling pathways.

  2012cited by this paper
• Therapeutic siRNA silencing in inflammatory monocytes

  2011cited by this paper
• Involvement of oxidative stress in simvastatin-induced apoptosis of murine CT26 colon carcinoma cells.

  2010cited by this paper
• Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles

  2008cited by this paper
• Anticancer Polymeric Nanomedicines

  2007cited by this paper
• Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach

  2006cited by this paper
• Comparison of the response of primary human blood monocytes and the U937 human monocytic cell line to two different sizes of alumina ceramic particles

  2004cited by this paper

• No citing papers are available for this paper.